Maybe there won't be any screaming about this stock. But there could be some buying.

AEM's 132% rally in a year, strong cash flows and project progress suggest more upside, backed by surging gold prices.

Netflix is delivering solid growth, but the stock has tumbled lately.

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for ...

Nvidia has gone from market darling to problem child in a matter of months, with violent swings that have left even seasoned ...

Dividend stocks have more than doubled the average annual return of non-payers over the previous 51 years. Though dividends are commonplace, some dividend groupings are exceptionally rare, such as the ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date. However, Vertex's shares plunged after the ...

If there's one thing that can quickly send a healthcare stock soaring, it's the approval of a key drug. Not only can that give investors confidence in a business's ability to bring products to market, ...